glp/gip/glucagon & cagrilintide 8mg/2mg Retatrutide is a “GLP-3” therapy, meaning it acts on three hormone receptors — GLP-1, GIP, and glucagon — to influence appetite regulation, blood sugar control, and energy expenditure. By working across these Glucagon-Like Peptide-2, GLP-2 (1-34), human

What should doctors do before prescribing these peptides

Injections avoid the need for gastrointestinal absorption and may be the appropriate route for specific persistent causes or higher-risk presentations

Published clinical trial data from Eli Lillys investigational Retatrutide program do not validate or authorize human use of this independently manufactured research product, which is designated exclusively for in vitro laboratory research

Can I use this combination long-term

The wound area was photographed immediately after wounding (0 hours), and again at 12 hours postscratch using brightfield exposure at 10 magnification on a Nikon eclipse 80i epifluorescence microscope